Liver TransplantationImmunosuppressive AgentsGraft RejectionKidney TransplantationTacrolimusLiver FailureGraft SurvivalTransplantationLiver DiseasesTissue DonorsPostoperative ComplicationsCyclosporineMycophenolic AcidLiving DonorsCytomegalovirus InfectionsEnd Stage Liver DiseaseTreatment OutcomeRetrospective StudiesLiver CirrhosisImmunosuppressionTime FactorsOrgan TransplantationTransplantation, HomologousHeart TransplantationTissue and Organ ProcurementLiverLung TransplantationHepatitis CTransplantsTransplantation ImmunologyImmunocompromised HostLiver NeoplasmsWaiting ListsGanciclovirAntiviral AgentsRecurrenceRisk FactorsPostoperative PeriodLiver Function TestsCadaverCytomegalovirusOpportunistic InfectionsFollow-Up StudiesCalcineurinDrug Therapy, CombinationMycosesAspergillosisBiopsyIncidenceSirolimusProspective StudiesLymphoproliferative DisordersRisk AssessmentRoseolovirus InfectionsHepatic ArterySurvival AnalysisMonitoring, ImmunologicBone Marrow TransplantationTransplantation ToleranceCreatinineAntifungal AgentsRenal InsufficiencySurvival RateCholestasisFatal OutcomeCarcinoma, HepatocellularKaplan-Meier EstimateReoperationHistocompatibility TestingBile Duct DiseasesHerpesvirus 6, HumanCohort StudiesPortal VeinKidney Failure, ChronicCholangitis, SclerosingHepacivirusKidneyAzathioprineBiliary Tract DiseasesMultivariate AnalysisHeart-Lung TransplantationLiver Cirrhosis, AlcoholicHepatitis C, ChronicBK VirusAlanine TransaminaseViremiaBronchiolitis ObliteransPatient SelectionDonor SelectionHepatitis BLiver RegenerationProportional Hazards ModelsDrug MonitoringHerpesvirus 7, HumanMuromonab-CD3Kidney DiseasesFatty LiverGlomerular Filtration RatePancreas TransplantationViral Load